Sotera Health Company faces three key risks that make it a cautious pick, according to a recent analysis. The company’s organic revenue growth averaged just 5% annually over the past two years, lagging its sector and hinting at weak demand in its core business. With only $1.19 billion in trailing revenue, its small scale limits bargaining power and customer trust in the heavily regulated healthcare industry. Additionally, its free cash flow margin fell by 8.4 percentage points over five years to 8.1%, signaling rising capital intensity. The stock trades at 18 times forward earnings, or $17.92 per share, and has underperformed the S&P 500 over the past six months.
Broadcom Inc
NVIDIA CorporationSotera Health CoOrganic revenue growth lagging sector suggests weak demand in core business
Crowdstrike Holdings Inc
Meta Platforms Inc.